Moreover, consistent with the large number of ETS targets in our infant-AML 56-gene signature, at least five genes in this network (IGF2BP1/3, LEF1, POU2AF1, CD79A) are also targeted by the infant-AML specific factor ETS1. Here, CD79A is linked to acute myeloid leukemia.